TickerFactsScreenerDevelopers

Outlook Therapeutics, Inc. (OTLK) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$46.56M2016: -$51.35M2017: -$35.88M2018: -$29.64M2019: -$36.30M2020: -$36.84M2021: -$51.73M2022: -$63.07M2023: -$53.13M2024: -$71.70M2025: -$67.06M-$67.06M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$67.06M+6.5%
2024-$71.70M-35.0%
2023-$53.13M+15.8%
2022-$63.07M-21.9%
2021-$51.73M-40.4%
2020-$36.84M-1.5%
2019-$36.30M-22.4%
2018-$29.64M+17.4%
2017-$35.88M+30.1%
2016-$51.35M-10.3%
2015-$46.56M—